What is peptid t?

Peptide T is a 31-amino acid peptide that was originally identified as a fragment of the neuropeptide substance P. It has been studied extensively for its potential therapeutic applications in HIV/AIDS and neurodegenerative diseases such as Alzheimer's and Parkinson's.

Peptide T works by binding to the CD4 receptor on T cells and inhibiting HIV-1 viral replication. It has been shown to have immunomodulatory effects by increasing T cell proliferation and cytokine production.

In addition to its potential use in treating HIV/AIDS, Peptide T has been studied for its neuroprotective properties. It has been shown to have a beneficial effect on cognitive function and memory in animal models of Alzheimer's and has also been investigated for its potential use in treating Parkinson's disease.

Despite promising results in early studies, Peptide T has not yet been approved for clinical use. Challenges have included difficulties with bioavailability and dosing, as well as limited understanding of its long-term safety and efficacy.